Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
maybe MM signals ?
there are so many 100x trades today, any reason why?
this will bounce soon
lets see if i get another 500K
i told you guys
my 500K are on the way
thx, soon ready to pick up another 500K
please how many shares left to 0,004?
how much do we have on ask 0,0038?
thats why i boght another 1,4M over the last two days,
any guess why ?
holding long and strong for 0,10 (first step)
ok guys, bought another 500K with 0,0039
thank you guys so much for that 0,004 , now i am having nearly 8.5m, i think a lot of them will regret it today in the evening...
0,004, but i am willing to slap ask soon if they dont sell it to me
i have a buy with 900K, lets see if i get filled
Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
Segment Scheduled to Air at 6 pm EST
WORCESTER, Mass. and TORONTO, Dec. 19, 2011 /PRNewswire via COMTEX/ -- Generex Biotechnology Corporation (OTCBB:GNBT.OB) today announced that Bloomberg Television is scheduled to air a segment on the immunotherapeutic breast cancer vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc. The segment is scheduled to air at 6 pm EST (3 pm PST) today, Monday, December 19, 2011 (see promo at http://i879.photobucket.com/albums/ab357/tc2000chartreader/72389a92.mp4. It is expected that, once aired, the segment will be available for viewing on the Bloomberg website and on the Generex website.
(Logo: http://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b )
The story will cover the Company's novel Ii-Key Hybrid-based HER-2/neu Peptide Vaccine (AE37), which is the subject of an ongoing Phase 2 clinical study in patients with HER-2 expressing breast cancer. The segment will be featured in Bloomberg's "Innovators" segment, which focuses on world-changing technologies and innovations.
The segment will include an interview by Bloomberg reporter Cali Carlin of Dr. Eric von Hofe, Ph.D., President of Antigen Express, and COL George E. Peoples, MD, FACS, Director, Cancer Vaccine Development Program.
Antigen Express has pioneered technology for increasing the potency of therapeutic anti-cancer vaccines. Initial clinical studies showed that its lead compound, AE37, indeed showed surprisingly potent immunological activity without sacrificing any specificity in the immune response. For the last four years, AE37 has been in a controlled, randomized Phase II study to determine whether it can indeed prevent recurrences in patients who have had breast cancer. Positive interim results from that study were recently presented at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). Final Phase 2 results are expected in 2012.
The Antigen Express AE37 breast cancer vaccine was also featured in Newsweek magazine on December 12, 2011 in science columnist and science editor Sharon Begley's article, Could This Be The End of Cancer?:(http://www.thedailybeast.com/newsweek/2011/12/11/could-this-be-the-end-of-cancer.html)."
About Generex Biotechnology Corporation
no.11 on breakout boards, getting more and more attention
i love to see these seel 100shares signals - MM need shares
can s.o. post level2 please
could s/o post realtime please for me
bid and ask
question:
that intraday chart doesnt work because of that 2 dollar fat fingerprint. any other links where i can see better realtime now ?
thx in adv.
question:
that intraday chart doesnt work because of that 2 dollar fatz fingerprint. any other links where i can see better realtime now ?
thx in adv.
We believe the impact and benefits of the THC e-cig are a game changer for not just our business but the industry as a whole," said Amezquita.
News:
Rapid Fire Marketing: Medical Cannabis Management Has Producer for THC e-Cig; Production to Begin immediately
CARSON CITY, Nev., Dec. 7, 2011 /PRNewswire via COMTEX/ -- Rapid Fire Marketing (Pink Sheets: RFMK) announced today that Medical Cannabis Management (MCM) has contracted with a producer for the THC cartridges with respect to their new product, a THC filled electronic cigarette. The laboratory MCM is using for development has documented the correct 'dosage' for the flavor/THC cartridges and this documentation will be sent to the producer within the next few days.
Time is of the essence and getting the new THC e-cigs to market is the number one priority of the company at this time. Initially, physicians and medical cannabis dispensaries will be the target of the Company' marketing efforts.
"We have worked very hard and went through a few producers before settling on the one we did," said Mike Amezquita, CEO of MCM. "Our goal is to have the new THC e-cigs to physicians and medical cannabis dispensaries as quickly as we can. We believe the impact and benefits of the THC e-cig are a game changer for not just our business but the industry as a whole," said Amezquita.
Safe Harbor:
From time to time, the Company may issue news releases that contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor created by those sections. This material may contain statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. For those statements, the Company claims the protection of the safe harbor for forward-looking statement provisions contained in the Private Securities Litigation Reform Act of 1995 and any amendments thereto. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be "forward-looking statements." "Forward-looking statements" are based upon expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those anticipated.
SOURCE Rapid Fire Marketing
www.prnewswire.com
already doubled my position today
long and strong holding 8m
it means it will skyrock
i just jumped in too
why there is such low trading vol today
only 4m?
this one i like most:
"We are confident we will be able to finalize excellent terms with the prominent cartridge producer in the very near future. Either way we are going to production soon," said Mike Amezquita, CEO of MCM. "I cannot describe how excited I am about this new product. While it is important to produce medical cannabis, having a much more viable delivery method is even more important. This could change the whole industry," said Amezquita.
NEWS:
Rapid Fire Marketing: Medical Cannabis Management's THC e-Cig Will Provide a Revolutionary New Delivery Method
CARSON CITY, Nev., Dec. 1, 2011 /PRNewswire via COMTEX/ -- Rapid Fire Marketing (OTC Pink: RFMK) announced today that Medical Cannabis Management (MCM) is in discussions with a prominent producer to fill the flavor cartridges with the prescribed amount of THC for the new electronic cigarette product announced on 29 November, 2011. MCM is narrowing down the provider of choice to ensure quality control and timely delivery of the product.
While the Company already has a long-standing relationship with its current supplier of Bionic brand electronic cigarettes, MCM has been in discussions with additional producers over the last several days. Management is confident an agreement can be reached because producers understand the impact and value of the new THC e-Cig.
Benefits of an electronic THC e-Cig cannot be underestimated given the size of the medical cannabis business. Some benefits include:
Smokeless - the new e-Cig with THC will allow the patient to consume the product without all of the harmful effects and carcinogens associated with actual smoke.
Can be used anywhere - patients can use the e-Cig anywhere. This eliminates the patient's need to find a safe place to "light up" because they are not actually lighting up. The active THC ingredient is vaporized, producing only a water vapor and eliminates the smell associated with traditional medical cannabis.
Eliminate the need to consistently keep inventory of medical cannabis - rather than using actual plant material, the THC is in an oil form that is added to the flavor cartridge of the THC e-Cig.
Professional product - the new THC e-Cig will be a professional product with a high level of quality control. Product and packaging will be professionally done and recognized as a reliable alternative for medical cannabis patients.
Significant marketing opportunity- the new THC e-Cig will be marketed to physicians and medical cannabis dispensaries. As mentioned in the prior news release, the market for the new cannabis electronic cigarettes is substantial given that 16 of the 50 states including the District of Columbia have legalized medical cannabis as a viable treatment for such diseases such as AIDS, multiple sclerosis, pain, glaucoma, epilepsy, and other conditions according to many sources.
"We are confident we will be able to finalize excellent terms with the prominent cartridge producer in the very near future. Either way we are going to production soon," said Mike Amezquita, CEO of MCM. "I cannot describe how excited I am about this new product. While it is important to produce medical cannabis, having a much more viable delivery method is even more important. This could change the whole industry," said Amezquita.
Safe Harbor:
From time to time, the Company may issue news releases that contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor created by those sections. This material may contain statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. For those statements, the Company claims the protection of the safe harbor for forward-looking statement provisions contained in the Private Securities Litigation Reform Act of 1995 and any amendments thereto. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be "forward-looking statements." "Forward-looking statements" are based upon expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those anticipated.
SOURCE Rapid Fire Marketing
www.prnewswire.com
OMG !!!
take a look at the 1year chart
maybe soon back to .025 and above
Let the games begin
nice 850K hit the ask
R.I.P. POS MSOA
News:
Micro Imaging Technology Introduces the MIT 1000A and a Family of Bacteria Identifying Software
SAN CLEMENTE, CA, Oct 18, 2011 (MARKETWIRE via COMTEX) -- Micro Imaging Technology, Inc. (OTCBB: MMTC) (OTCQB: MMTC) announced today the volume availability in early 2012 of the MIT 1000A (Figure 1). The System, manufactured exclusively for MIT by Hawthorne, CA-based OSI Optoelectronics, Inc., is a stand-alone optically-based microbial identification system that uses proven principles of physics in conjunction with proprietary PC-based software and is totally USB compliant. The thoroughly green system can currently identify over twenty different species of bacteria without the use of chemicals, reagents, dyes or DNA processing. The only additive is clean water and a sample of the unknown bacteria. In addition to bacteria other microbes can be easily added to the System's identifying capabilities, including; protozoa, fungi, yeast and mold. The MIT 1000A can complete an identifying test in less than five (5) minutes and with a material cost of pennies -- adding further credence to MIT's claims of being able to annually save thousands of lives and tens of millions of dollars in health care costs.
As further explained by MIT's Chief Scientist, David Haavig, PhD, "The MIT 1000A is a natural evolution from our earlier MIT 1000 System, without changing the basic science -- but with specific added capabilities. The USB connectivity enables the instrument to attach directly to the user's PC and allows the software operating system and microbial identifiers to be provided separately by MIT."
Figure 1 -- MIT 1000A
As previously mentioned, over ninety percent of all infectious food contaminations are caused by E.coli, Salmonella or Listeria -- which annually causes hundreds of deaths and thousands of hospitalizations. Also the recall of millions of pounds of processed meats, dairy, fish and poultry products and numerous crops of lettuce, spinach, peppers, peanuts, melons and tomatoes.
The Company's objective is the continual expansion of MIT's proprietary Microbe Library -- the repository of the identifiers for bacteria and other microbes. The process for entering a microbe identifier is to evaluate the specie in MIT's Laboratory with hundreds of thousands of measurements and statistically prove the uniqueness of the identifier. That identifier is then compared with other datum and then added to the Microbe Library.
About Micro Imaging Technology:
MIT is a California-based public company that has developed and patented a Microbial Identification System that revolutionizes the pathogenic bacteria diagnostic process. The System identifies bacteria in minutes, not days, and at a significant per test cost savings when compared to any other conventional method. Revenues for all rapid testing methods exceed $5 billion annually -- with food safety accounting for over $3.5 billion, which is expected to surpass $4.7 billion by 2015 according to BCC Research. In addition, the recently passed "New" U.S. Food Safety Bill is expected to further accelerate the current annual growth rate of 6.6 percent.
MIT previously completed an extensive evaluation by the AOAC Research Institute (AOAC RI) which included rigorous independent testing and thorough reviews by its expert examiners, including the U.S. Department of Agriculture. This evaluation process resulted in MIT being awarded the prestigious AOAC RI Certificate of Performance Testing (Certificate No. 060901). The AOAC RI Report is available from the Company. www.aoac.org
MIT also demonstrated the ability to detect and identify, within several minutes, the microbes Escherichia coli, Listeria, Salmonella, Staphylococcus aureus, and other pathogenic bacteria. This identification process was verified by North American Science Associates, Inc. ("NAMSA"), an independent and internationally recognized bioscience testing laboratory. The NAMSA Test Report is also available from the Company and, in MIT's opinion, demonstrates the accuracy, speed and cost effectiveness of the System over conventional processes. www.namsa.com
This release contains statements that are forward-looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the U.S. Securities and Exchange Commission, reference MMTC: www.sec.gov.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=1768739
CONTACT:
Michael Brennan
Chairman
Email: Email Contact
Web Site: www.micro-imaging.com
Telephone: (805) 557-0614
SOURCE: Micro Imaging Technology, Inc.
i remember that run last time up to 0,025
hugh buys coming in now
HUGH NEWS !!!!
Rapid Fire Marketing: No Reverse Split
Company to File for OTCBB
CARSON CITY, Nev., Oct. 4, 2011 /PRNewswire via COMTEX/ -- Rapid Fire Marketing (OTC Pink: RFMK) announced today that the Company has no immediate or long-term plans to recapitalize or effect a reverse split on the stock. Additionally, the Company plans to begin the process of filing a Registration Statement with the SEC to be listed on the OTCBB by early 2012.
Over the last several months, Rapid Fire Marketing has made significant progress to move the business of Medical Cannabis Management (MCM) forward. MCM is now capitalized and is in process of generating revenues. Shareholders have voiced concerns to the Company regarding a reverse split because the stock price has suffered under difficult market conditions. Rapid Fire Marketing's Management feels that with all businesses now in operation and moving forward quickly, that there will be no need to have a reverse split on the stock.
"At this point, all of our businesses are moving along and we see revenues starting to come in," said Mike Amezquita, CEO of MCM. "As revenues grow and the Company becomes profitable, we will no longer need to raise capital, so we believe that a reverse split of any kind would be very counterproductive and would hurt our Company and our shareholders. We are doing everything we can to ensure that our Company performs now and into the future. The Company is in final discussions to determine the best route to become a fully-reporting company on the OTCBB. We believe that getting a Registration Statement done through our attorneys will give us better visibility and enable our Company to function at a higher level on the OTCBB," said Amezquita.
Safe Harbor:
From time to time, the Company may issue news releases that contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor created by those sections. This material may contain statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. For those statements, the Company claims the protection of the safe harbor for forward-looking statement provisions contained in the Private Securities Litigation Reform Act of 1995 and any amendments thereto. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be "forward-looking statements." "Forward-looking statements" are based upon expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those anticipated.
SOURCE Rapid Fire Marketing
www.prnewswire.com
Copyright (C) 2011 PR Newswire. All rights reserved
easy 10bagger - look at chart 6 months ago, we were at 0,025
ready to move, nice 500K slapped the ask
here we go
10 K on the way ?